Screening of gastric cancer in Asia.
暂无分享,去创建一个
[1] Manami Inoue,et al. Gastric cancer screening and subsequent risk of gastric cancer: A large‐scale population‐based cohort study, with a 13‐year follow‐up in Japan , 2006, International journal of cancer.
[2] K. Matsushita,et al. Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis , 2011, Journal of Gastroenterology.
[3] J. Tashiro,et al. Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker , 2013, Gastric Cancer.
[4] I. Choi,et al. Performance of Different Gastric Cancer Screening Methods in Korea: A Population-Based Study , 2012, PloS one.
[5] M. Gail,et al. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. , 2014, Journal of the National Cancer Institute.
[6] S. Shirahama,et al. Results of mass endoscopic examination for gastric cancer in Kamigoto Hospital, Nagasaki Prefecture. , 2007, World journal of gastroenterology.
[7] K. Miki. Gastric cancer screening using the serum pepsinogen test method , 2002, Gastric Cancer.
[8] Fang Wang,et al. Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis , 2015, Scientific Reports.
[9] N. Yoshimura,et al. Gastric cancer screening of a high‐risk population in Japan using serum pepsinogen and barium digital radiography , 2005, Cancer science.
[10] P. Malfertheiner,et al. Kyoto global consensus report on Helicobacter pylori gastritis , 2015, Gut.
[11] I. Choi,et al. Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea , 2014, British Journal of Cancer.
[12] Yuan Yuan. A survey and evaluation of population-based screening for gastric cancer , 2013, Cancer biology & medicine.
[13] M. Vieth,et al. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication , 2015, Gut.
[14] M. Kodaira,et al. Serum pepsinogens as an early diagnostic marker of H. pylori eradication. , 2008, Hepato-gastroenterology.
[15] T. Chen,et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention , 2012, Gut.
[16] Hossam Haick,et al. Detection of precancerous gastric lesions and gastric cancer through exhaled breath , 2015, Gut.
[17] Shengyong Fu,et al. The diagnostic value of monoclonal gastric cancer 7 antigen: a systematic review with meta-analysis , 2014, Clinical and Experimental Medicine.
[18] Y. Sugisaki,et al. Helicobacter pylori infection‐negative gastric cancer in Japanese hospital patients: Incidence and pathological characteristics , 2007, Cancer science.
[19] M. Inoue,et al. Effect of Helicobacter pylori Infection Combined with CagA and Pepsinogen Status on Gastric Cancer Development among Japanese Men and Women: A Nested Case-Control Study , 2006, Cancer Epidemiology Biomarkers & Prevention.
[20] N. Yamamichi,et al. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer , 2014, International journal of cancer.
[21] J. So,et al. Endoscopic screening for gastric cancer. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[22] H. Tajiri,et al. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk , 2011, Journal of Gastroenterology.
[23] K. Choi,et al. Screening for Gastric Cancer in Korea: Population-Based Preferences for Endoscopy versus Upper Gastrointestinal Series , 2009, Cancer Epidemiology Biomarkers & Prevention.
[24] Ming-Fang Yen,et al. Cost-effectiveness Analysis between Primary and Secondary Preventive Strategies for Gastric Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.
[25] Y. Yamaji,et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study , 2005, Gut.
[26] Wei-Chih Liao,et al. Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions , 2013, BMJ Open.
[27] M. Kaminishi,et al. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. , 2011, Gastroenterology.
[28] R. Hunt,et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials , 2014, BMJ : British Medical Journal.
[29] T. Azuma,et al. Prescreening of a High-Risk Group for Gastric Cancer by Serologically Determined Helicobacter pylori Infection and Atrophic Gastritis , 2010, Digestive Diseases and Sciences.
[30] Anna Trakoli. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 99: Some Aromatic Amines, Organic Dyes, and Related Exposures. International Agency for Research on Cancer , 2012 .
[31] A. Tashiro,et al. Comparing mass screening techniques for gastric cancer in Japan. , 2006, World journal of gastroenterology.
[32] H. Yatsuya,et al. Prospective study of screening for stomach cancer in Japan , 2003, International journal of cancer.
[33] M A Fujino,et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations , 1999, Gut.
[34] N. Naidoo,et al. A Cost-Effectiveness Analysis Evaluating Endoscopic Surveillance for Gastric Cancer for Populations with Low to Intermediate Risk , 2013, PloS one.
[35] Khean Lee Goh,et al. Screening for gastric cancer in Asia: current evidence and practice. , 2008, The Lancet. Oncology.
[36] M. Gail,et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. , 2012, Journal of the National Cancer Institute.
[37] K. Sugano,et al. Clinical Management of Helicobacter pylori - The Japanese Perspective , 2014, Digestive Diseases.
[38] D. Graham,et al. Mass Eradication of Helicobacter pylori to Prevent Gastric Cancer: Theoretical and Practical Considerations , 2016, Gut and liver.
[39] K. Murakami,et al. Tu1056 A Phase 3, Double-Blind Study of a Triple Therapy With TAK-438, Amoxicillin, and Clarithromycin As First Line Eradication of H. pylori and a Triple Therapy With TAK-438, Amoxicillin, and Metronidazole As Second Line Eradication of H. pylori , 2014 .
[40] C. Crespi,et al. Colorectal cancer among Koreans living in South Korea versus California: incidence, mortality, and screening rates , 2014, Ethnicity & health.
[41] K. Miki. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method” , 2011, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[42] M. Asaka,et al. Recent development of gastric cancer prevention. , 2012, Japanese journal of clinical oncology.
[43] Kazuhide Yamamoto,et al. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori , 2011, Journal of Gastroenterology.
[44] C. Hamashima,et al. A Community-Based, Case-Control Study Evaluating Mortality Reduction from Gastric Cancer by Endoscopic Screening in Japan , 2013, PloS one.
[45] K. Choi,et al. Gastric Cancer Screening Uptake Trends in Korea: Results for the National Cancer Screening Program From 2002 to 2011 , 2015, Medicine.
[46] K. Haruma,et al. Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: A case-control study , 2007, Scandinavian journal of gastroenterology.
[47] Masakazu Hattori,et al. Decreased death from gastric cancer by endoscopic screening: Association with a population-based cancer registry , 2008, Scandinavian journal of gastroenterology.
[48] S. Menon,et al. How commonly is upper gastrointestinal cancer missed at endoscopy? A meta-analysis , 2014, Endoscopy International Open.
[49] J. Otaki,et al. Prevalence of Helicobacter pylori infection with healthy subjects in Japan , 2014, Journal of gastroenterology and hepatology.
[50] T. Itoi,et al. Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan , 2007, Inflammopharmacology.
[51] K. Choi,et al. Comparing upper gastrointestinal X-ray and endoscopy for gastric cancer diagnosis in Korea. , 2010, World journal of gastroenterology.
[52] C. Hamashima. Current issues and future perspectives of gastric cancer screening. , 2014, World journal of gastroenterology.
[53] K. Murakami,et al. Prevalence of Helicobacter pylori Infection by Birth Year and Geographic Area in Japan , 2014, Helicobacter.
[54] T. Gotoda,et al. Detection of early gastric cancer: misunderstanding the role of mass screening , 2006, Gastric Cancer.
[55] Tomotaka Sobue,et al. The Japanese guidelines for gastric cancer screening. , 2008, Japanese journal of clinical oncology.
[56] K. Yao,et al. New Diagnostic Approaches for Early Detection of Gastric Cancer , 2005, Digestive Diseases.